| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Chicago |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000265 |
Purpose
The purpose of this study is to assess the subjective effects of nitrous oxide in dental patients.
| Condition | Intervention | Phase |
|
Opioid-Related Disorders Substance-Related Disorders |
Drug: Nitrous oxide |
Phase II |
| Drug Information available for: | Nitrous oxide |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Subjective Effects of Nitrous Oxide in Dental Patients |
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, Illinois | |||||
| University of Chicago, Anesthesia & Critical Care | |||||
| Chicago, Illinois, United States, 60637 | |||||
| National Institute on Drug Abuse (NIDA) |
| University of Chicago |
| Principal Investigator: | James Zacny, Ph.D. | University of Chicago |
More Information
| Study ID Numbers: | NIDA-08391-17, R01-08391-17 |
| First Received: | September 20, 1999 |
| Last Updated: | August 16, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000265 |
| Health Authority: | United States: Federal Government |
|
|
|
|
